0001785686-19-000001.txt : 20190822 0001785686-19-000001.hdr.sgml : 20190822 20190821192106 ACCESSION NUMBER: 0001785686-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190822 DATE AS OF CHANGE: 20190821 EFFECTIVENESS DATE: 20190822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RadImmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001785686 IRS NUMBER: 812848420 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-347151 FILM NUMBER: 191044037 BUSINESS ADDRESS: STREET 1: 303 SOUTH BROADWAY, SUITE 105 CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: (914) 332-5393 MAIL ADDRESS: STREET 1: 303 SOUTH BROADWAY, SUITE 105 CITY: TARRYTOWN STATE: NY ZIP: 10591 D 1 primary_doc.xml X0708 D LIVE 0001785686 RadImmune Therapeutics, Inc. 303 SOUTH BROADWAY, SUITE 105 TARRYTOWN NY NEW YORK 10591 (914) 332-5393 DELAWARE None None Corporation true 2016 Jack Hidary c/o RadImmune Therapeutics, Inc. 303 South Broadway, Ste. 105 Tarrytown NY NEW YORK 10591 Executive Officer Director Josh Becker c/o RadImmune Therapeutics, Inc. 303 South Broadway, Ste. 105 Tarrytown NY NEW YORK 10591 Director Ron Lennox c/o RadImmune Therapeutics, Inc. 303 South Broadway, Ste. 105 Tarrytown NY NEW YORK 10591 Director Other Health Care Decline to Disclose 06b false 2019-08-02 false true false 1 21786785 13560985 8225800 false 14 0 0 0 false RadImmune Therapeutics, Inc. /s/ Jack Hidary Jack Hidary Chief Executive Officer 2019-08-21